"PD-L1 Status as a Biomarker in NSCLC: What the numbers really tell us" Barry Paul, MD 2nd Year Hem Onc Fellow “Radiotherapy for Oligometastases” Joseph Salama, MD Associate Professor Residency Program Director Department of Radiation Oncology Duke Unive